KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Novavax (NVAX) Short-Term Debt issuances (2016)

Historic Short-Term Debt issuances for Novavax (NVAX) over the last 8 years, with Q4 2016 value amounting to -$45000.0.

  • Novavax's Short-Term Debt issuances rose 6830.99% to -$45000.0 in Q4 2016 from the same period last year, while for Sep 2017 it was -$45000.0, marking a year-over-year increase of 9085.37%. This contributed to the annual value of -$395000.0 for FY2016, which is 3416.67% up from last year.
  • Latest data reveals that Novavax reported Short-Term Debt issuances of -$45000.0 as of Q4 2016, which was up 6830.99% from -$104000.0 recorded in Q3 2016.
  • In the past 5 years, Novavax's Short-Term Debt issuances ranged from a high of -$7000.0 in Q2 2012 and a low of -$170000.0 during Q2 2014
  • Moreover, its 5-year median value for Short-Term Debt issuances was -$143000.0 (2015), whereas its average is -$115736.8.
  • In the last 5 years, Novavax's Short-Term Debt issuances tumbled by 128571.43% in 2013 and then soared by 6830.99% in 2016.
  • Quarter analysis of 5 years shows Novavax's Short-Term Debt issuances stood at -$40000.0 in 2012, then plummeted by 320.0% to -$168000.0 in 2013, then grew by 1.19% to -$166000.0 in 2014, then grew by 14.46% to -$142000.0 in 2015, then soared by 68.31% to -$45000.0 in 2016.
  • Its last three reported values are -$45000.0 in Q4 2016, -$104000.0 for Q3 2016, and -$103000.0 during Q2 2016.